INNOVATION PHARMACEUTICALS INC. Accrued Salaries, Current
INNOVATION PHARMACEUTICALS INC. had Accrued Salaries, Current of $1.51 million as of 2023-09-30, per its 10-Q filed 2023-11-20.
Discontinued › Notes › Payables and Accruals › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current › Employee-related Liabilities, Current
us-gaap:AccruedSalariesCurrent · last filed 2023-11-20
- 2023-09-30: Accrued Salaries, Current $1.51M.
- 2023-06-30: Accrued Salaries, Current $1.61M.
- 2023-03-31: Accrued Salaries, Current $1.60M.
- 2022-12-31: Accrued Salaries, Current $1.59M.
| Period end | Accrued Salaries, Current |
|---|---|
| 2023-09-30 | $1.51M 10-Q · filed 2023-11-20 |
| 2023-06-30 | $1.61M 10-Q · filed 2023-11-20 |
| 2023-03-31 | $1.60M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $1.59M 10-Q · filed 2023-02-15 |
| 2022-06-30 | $1.56M 10-K · filed 2023-09-28 |
| 2021-09-30 | $1.65M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $1.99M 10-Q · filed 2021-11-09 |
| 2020-06-30 | $3.21M 10-K · filed 2020-09-14 |
| 2020-03-31 | $118.00K 10-Q · filed 2020-05-14 |
| 2019-12-31 | $3.36M 10-Q · filed 2020-02-13 |
| 2019-09-30 | $3.20M 10-Q · filed 2019-11-13 |
| 2019-06-30 | $3.16M 10-K · filed 2020-09-14 |
| 2018-06-30 | $3.22M 10-K · filed 2019-09-30 |
| 2017-06-30 | $86.00K 10-Q · filed 2018-05-10 |
| 2017-03-31 | $2.65M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $2.65M 10-Q · filed 2017-02-09 |
| 2016-09-30 | $2.65M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $2.65M 10-Q · filed 2017-05-09 |
| 2016-03-31 | $2.65M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $2.65M 10-Q · filed 2016-02-08 |
| 2015-09-30 | $2.65M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $2.65M 10-K · filed 2016-09-13 |
| 2015-03-31 | $2.65M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $2.84M 10-Q · filed 2015-02-09 |
| 2014-09-30 | $3.03M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $3.03M 10-K · filed 2015-09-11 |
| 2014-03-31 | $3.03M 10-Q/A · filed 2014-05-16 |
| 2013-12-31 | $3.03M 10-Q · filed 2014-02-10 |
| 2013-09-30 | $3.24M 10-Q · filed 2013-11-08 |
| 2013-06-30 | $3.24M 10-K · filed 2014-09-15 |
| 2013-03-31 | $3.24M 10-Q · filed 2013-05-20 |
| 2012-06-30 | $2.65M 10-K · filed 2013-09-30 |